Lancet 400(10366):18691881 Jastreboff AM, Kaplan LM, Fras JP, Wu Q, Du Y, Gurbuz S et al (2023) Retatrutide phase 2 obesity trial investigators
If you have questions about your specific targets, bring them to your next check-in.
A key extrinsic pathway component is the death receptor Fas (CD95), which, upon binding to Fas ligand (FasL/CD95L), recruits the adaptor protein FADD (Fas-associated death domain protein) and procaspase-8 to form the death-inducing signaling complex (DISC)
A novel GLP-1 and FGF21 fusion protein for the treatment of non-alcoholic steatohepatitis (NASH)
Zonulin is a protein that controls how tightly your intestinal cells stay sealed together
Track your dose history, phase in your cycle, estimated medication levels, and upcoming injection dates with reminders so you never miss a scheduled shot